192 related articles for article (PubMed ID: 20309753)
21. What we want versus what we can get: a closer look at failure time endpoints for cardiovascular studies.
Song R; Cook TD; Kosorok MR
J Biopharm Stat; 2008; 18(2):370-81. PubMed ID: 18327727
[TBL] [Abstract][Full Text] [Related]
22. Comments on the FDA draft guidance on adaptive designs.
Wittes J
J Biopharm Stat; 2010 Nov; 20(6):1166-70. PubMed ID: 21058112
[No Abstract] [Full Text] [Related]
23. Statistical methods for microarray assays.
Krajewski P; Bocianowski J
J Appl Genet; 2002; 43(3):269-78. PubMed ID: 12177516
[TBL] [Abstract][Full Text] [Related]
24. Two new covariate adjustment methods for non-inferiority assessment of binary clinical trials data.
Hou Y; Ding V; Li K; Zhou XH
J Biopharm Stat; 2011 Jan; 21(1):77-93. PubMed ID: 21191856
[TBL] [Abstract][Full Text] [Related]
25. Statistical principles for omics-based clinical trials.
Sachs MC
Chin Clin Oncol; 2015 Sep; 4(3):29. PubMed ID: 26408296
[TBL] [Abstract][Full Text] [Related]
26. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
27. Calculation of tolerance limits and sample size determination for clinical trials with dichotomous outcomes.
Zaslavsky BG
J Biopharm Stat; 2007; 17(3):481-91. PubMed ID: 17479395
[TBL] [Abstract][Full Text] [Related]
28. Computational biology: toward deciphering gene regulatory information in mammalian genomes.
Ji H; Wong WH
Biometrics; 2006 Sep; 62(3):645-63. PubMed ID: 16984301
[TBL] [Abstract][Full Text] [Related]
29. Guest editors' note: Special issue associated with the 2013 ASA Biopharmaceutical FDA/Industry Statistics Workshop.
Binkowitz B; Yue LQ
J Biopharm Stat; 2014; 24(5):965-7. PubMed ID: 25014118
[No Abstract] [Full Text] [Related]
30. Introduction to discussion papers on draft FDA guidance on adaptive designs.
Chang M
J Biopharm Stat; 2010 Nov; 20(6):1113-4. PubMed ID: 21058106
[No Abstract] [Full Text] [Related]
31. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine.
Collins CD; Purohit S; Podolsky RH; Zhao HS; Schatz D; Eckenrode SE; Yang P; Hopkins D; Muir A; Hoffman M; McIndoe RA; Rewers M; She JX
Vascul Pharmacol; 2006 Nov; 45(5):258-67. PubMed ID: 17030152
[TBL] [Abstract][Full Text] [Related]
32. Interpreting P values in pharmacogenetic studies: a call for process and perspective.
Maitland ML; Ratain MJ; Cox NJ
J Clin Oncol; 2007 Oct; 25(29):4513-5. PubMed ID: 17925544
[No Abstract] [Full Text] [Related]
33. Editorial: Adaptive designs: appealing in development of therapeutics, and where do controversies lie?
Wang SJ
J Biopharm Stat; 2010 Nov; 20(6):1083-7. PubMed ID: 21058102
[No Abstract] [Full Text] [Related]
34. [Genomic classification of diseases].
Orntoft TF
Ugeskr Laeger; 2005 May; 167(20):2164-7. PubMed ID: 15987074
[No Abstract] [Full Text] [Related]
35. Clinical genomics data standards for pharmacogenetics and pharmacogenomics.
Shabo A
Pharmacogenomics; 2006 Mar; 7(2):247-53. PubMed ID: 16515405
[TBL] [Abstract][Full Text] [Related]
36. Outcome reporting bias in clinical trials.
Esposito E; Cipriani A; Barbui C
Epidemiol Psichiatr Soc; 2009; 18(1):17-8. PubMed ID: 19378694
[No Abstract] [Full Text] [Related]
37. Pharmacogenomics in the evaluation of efficacy and adverse events during clinical development of vaccines.
Nilsson LJ; Regnström KJ
Methods Mol Biol; 2008; 448():469-79. PubMed ID: 18370243
[TBL] [Abstract][Full Text] [Related]
38. Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century.
Schnackenberg LK
Expert Rev Mol Diagn; 2007 May; 7(3):247-59. PubMed ID: 17489732
[TBL] [Abstract][Full Text] [Related]
39. GEAMM v.1.4: a versatile program for mixed model analysis of gene expression data.
Casellas J; Ibáñez-Escriche N; Martínez-Giner M; Varona L
Anim Genet; 2008 Feb; 39(1):89-90. PubMed ID: 18076745
[No Abstract] [Full Text] [Related]
40. Genetics for the pediatric anesthesiologist: a primer on congenital malformations, pharmacogenetics, and proteomics.
Galinkin JL; Demmer L; Yaster M
Anesth Analg; 2010 Nov; 111(5):1264-74. PubMed ID: 20841405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
